A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA- editing enzyme

Genes and Development

Volumn 11, Issue 3, 1997, Pages 321-333

  Yamanaka, Shinya ^c   Poksay, Karen S ^a   Arnold, Kay S ^a   Innerarity, Thomas L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

APOBEC 1; RNA editing; transgenic mice; translation repressor

Indexed keywords

APOLIPOPROTEIN B; ENZYME; INITIATION FACTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; LIVER TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPRESSOR GENE; RNA EDITING; TRANSGENE; TRANSGENIC MOUSE; TRANSLATION REGULATION;

EID: 0031048641     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.3.321     Document Type: Article

References (66)

1. Adams, M.D., M. Dubnick, A.R. Kerlavage, R. Moreno, J.M. Kelley, T.R. Utterback, J.W. Nagle, C. Fields, and J.C. Venter. 1992. Sequence identification of 2,375 human brain genes. Nature. 355: 632-634.
2. Allen, M.L., A.M. Metz, R.T. Timmer, R.E. Rhoads, and K.S. Browning. 1992. Isolation and sequence of the cDNAs encoding the subunits of the isozyme form of wheat protein synthesis initiation factor 4F. J. Biol. Chem. 267: 23232-23236.
3. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
4. Anant, S., A.J. MacGinnitie, and N.O. Davidson. 1995. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J. Biol. Chem. 270: 14762-14767.
5. Backus, J.W. and H.C. Smith. 1994. Specific 3′ sequences flanking a minimal apolipoprotein B (apoB) mRNA editing "cassette" are critical for efficient editing in vitro. Biochim. Biophys. Acta. 1217: 65-73.
6. Backus, J.W., D. Schock, and H.C. Smith. 1994. Only cytidines 5′ of the apolipoprotein B mRNA mooring sequence are edited. Biochim. Biophys. Acta. 1219: 1-14.
7. Bokros, C.L., J.D. Hugdahl, H.-H. Kim, V.R. Hanesworth, A. van Heerden, K.S. Browning, and L.C. Morejohn. 1995. Function of the p86 subunit of eukaryotic initiation factor (iso)4F as a microtubule-associated protein in plant cells. Proc. Natl. Acad. Sci. 92: 7120-7124.
8. Boström, K., S.J. Lauer, K.S. Poksay, Z. Garcia, J.M. Taylor, and T.L. Innerarity. 1989. Apolipoprotein B48 RNA editing in chimeric apolipoprotein EB mRNA. J. Biol. Chem. 264: 15701-15708.
9. Chen, S.-H., G. Habib, C.-Y. Yang, Z.-W. Gu, B.R. Lee, S.-A. Weng, S.R. Silberman, S.-J. Cai, J.P. Deslypere, M. Rosseneu, A.M. Gotto, Jr., W.-H. Li, and L. Chan. 1987. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363-366.
10. De Benedetti, A. and R.E. Rhoads. 1990. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. 87: 8212-8216.
11. Donzé, O., R. Jagus, A.E. Koromilas, J.W.B. Hershey, and N. Sonenberg. 1995. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14: 3828-3834.
12. Driscoll, D.M. and Q. Zhang. 1994. Expression and characterization of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. J. Biol. Chem. 269: 19843-19847.
13. Driscoll, D.M., S. Lakhe-Reddy, L.M. Oleksa, and D. Martinez. 1993. Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA. Mol. Cell. Biol. 13: 7288-7294.
14. Frohman, M.A., M.K. Dush, and G.R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. 85: 8998-9002.
15. Gan, W. and R.E. Rhoads. 1996. Internal initiation of translation directed by the 5′-untranslated region of the mRNA for eIF4G, a factor involved in the picornavirus-induced switch from cap-dependent to internal initiation. J. Biol. Chem. 271: 623-626.
16. Giannoni, F., D.K. Bonen, T. Funahashi, C. Hadjiagapiou, C.F. Burant, and N.O. Davidson. 1994. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J. Biol. Chem. 269: 5932-5936.
17. Goyer, C., M. Altmann, H.S. Lee, A. Blanc, M. Deshmukh, J.L. Woolford, Jr., H. Trachsel, and N. Sonenberg. 1993. TIF4631 and TIF4632: Two yeast genes encoding the high-molecular-weight subunits of the cap-binding protein complex (eukaryotic initiation factor 4F) contain an RNA recognition motif-like sequence and carry out an essential function. Mol. Cell. Biol. 13: 4860-4874.
18. Greenberg, M.E. and J.G. Belasco. 1993. Control of the decay of labile protooncogene and cytokine mRNAs. In Control of messenger RNA stability (ed. J.G. Belasco and G. Brawerman), pp. 199-218. Academic Press, San Diego, CA.
19. Greeve, J., I. Altkemper, J.-H. Dieterich, H. Greten, and E. Windler. 1993. Apolipoprotein B mRNA editing in 12 different mammalian species: Hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34: 1367-1383.
20. Hann, S.R. 1994. Regulation and function of non-AUG-initiated proto-oncogenes. Biochimie 76: 880-886.
21. Harris, S.G., I. Sabio, E. Mayer, M.F. Steinberg, J.W. Backus, J.D. Sparks, C.E. Sparks, and H.C. Smith. 1993. Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins. J. Biol. Chem. 268: 7382-7392.
22. Hentze, M.W. 1995. Translational regulation: Versatile mechanisms for metabolic and developmental control. Curr. Opin. Cell Biol. 7: 393-398.
23. Hershey, J.W.B. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60: 717-755.
24. Hirano, K.-I., S.G. Young, R.V. Farese, Jr., J. Ng, E. Sande, C. Warburton, L.M. Powell-Braxton, and N.O. Davidson. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271: 9887-9890.
25. Hu, C., S. Pang, X. Kong, M. Velleca, and J.C. Lawrence, Jr. 1994. Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc. Natl. Acad. Sci. 91: 3730-3734.
26. Innerarity, T.L., J. Borén, S. Yamanaka, and S.-O. Olofsson. 1996. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J. Biol. Chem. 271: 2353-2356.
27. Jaramillo, M., T.E. Dever, W.C. Merrick, and N. Sonenberg. 1991a. RNA unwinding in translation: Assembly of helicase complex intermediates comprising eukaryotic initiation factors eIF-4F and eIF-4B. Mol. Cell. Biol. 11: 5992-5997.
28. Jaramillo, M., J. Pelletier, I. Edery, P.J. Nielsen, and N. Sonenberg. 1991b. Multiple mRNAs encode the murine translation initiation factor eIF-4E. J. Biol. Chem. 266: 10446-10451.
29. Kerekatte, V., K. Smiley, B. Hu, A. Smith, F. Gelder, and A. De Benedetti. 1995. The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas. Int. J. Cancer. 64: 27-31.
30. Koromilas, A.E., S. Roy, G.N. Barber, M.G. Katze, and N. Sonenberg. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685-1689.
31. Kozak, M. 1991. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 115: 887-903.
32. Lamphear, B.J., R. Yan, F. Yang, D. Waters, H.-D. Liebig, H. Klump, E. Kuechler, T. Skern, and R.E. Rhoads. 1993. Mapping the cleavage site in protein synthesis initiation factor eIF-4γ of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 268: 19200-19203.
33. Lamphear, B.J., R. Kirchweger, T. Skern, and R.E. Rhoads. 1995. Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J. Biol. Chem. 270: 21975-21983.
34. Lazaris-Karatzas, A., K.S. Montine, and N. Sonenberg. 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345: 544-547.
35. Lengyel, P. 1993. Tumor-suppressor genes: News about the interferon connection. Proc. Natl. Acad. Sci. 90: 5893-5895.
36. Liang, P. and A.B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971.
37. Lin, T.-A., X. Kong, T.A.J. Haystead, A. Pause, G. Belsham, N. Sonenberg, and J.C. Lawrence, Jr. 1994. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266: 653-656.
38. Mader, S., H. Lee, A. Pause, and N. Sonenberg. 1995. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4γ and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15: 4990-4997.
39. Mano, H., F. Ishikawa, J. Nishida, H. Hirai, and F. Takaku. 1990. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene 5: 1781-1786.
40. Merrick, W.C. 1992. Mechanism and regulation of eukaryotic protein synthesis. Microbiol Rev. 56: 291-315.
41. Meurs, E.F., J. Galabru, G.N. Barber, M.G. Katze, and A.G. Hovanessian. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. 90: 232-236.
42. Miyagi, Y., A. Sugiyama, A. Asai, T. Okazaki, Y. Kuchino, and S.J. Kerr. 1995. Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines. Cancer Lett. 91: 247-252.
43. Morris, D.R. 1995. Growth control of translation in mammalian cells. Prog. Nucleic Acid Res. Mol. Biol. 51: 339-363.
44. Morrison, J.R., C. Pászty, M.E. Stevens, S.D. Hughes, T. Forte, J. Scott, and E.M. Rubin. 1996. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc. Natl. Acad. Sci. 93: 7154-7159.
45. Navaratnam, N., J.R. Morrison, S. Bhattacharya, D. Patel, T. Funahashi, F. Giannoni, B.-B. Teng, N.O. Davidson, and J. Scott. 1993. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268: 20709-20712.
46. Navaratnam, N., S. Bhattacharya, T. Fujino, D. Patel, A.L. Jarmuz, and J. Scott. 1995. Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81: 187-195.
47. Nielsen, P.J., G.K. McMaster, and H. Trachsel. 1985. Cloning of eukaryotic protein synthesis initiation factor genes: Isolation and characterization of cDNA clones encoding factor eIF-4A. Nucleic Acids Res. 13: 6867-6880.
48. Ohlmann, T., M. Rau, V.M. Pain, and S.J. Morley. 1996. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E. EMBO J. 15: 1371-1382.
49. Pause, A., G.J. Belsham, A.-C. Gingras, O. Donzé, T.-A. Lin, J.C. Lawrence, Jr., and N. Sonenberg. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371: 762-767.
50. Powell, L.M., S.C. Wallis, R.J. Pease, Y.H. Edwards, T.J. Knott, and J. Scott. 1987. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50: 831-840.
51. Rhoads, R.E. 1993. Regulation of eukaryotic protein synthesis by initiation factors. J. Biol. Chem. 268: 3017-3020.
52. Rozen, F., I. Edery, K. Meerovitch, T.E. Dever, W.C. Merrick, and N. Sonenberg. 1990. Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol. Cell. Biol. 10: 1134-1144.
53. Scott, J. 1995. A place in the world for RNA editing. Cell 81: 833-836.
54. Shah, R.R., T.J. Knott, J.E. Legros, N. Navaratnam, J.C. Greeve, and J. Scott. 1991. Sequence requirements for the editing of apolipoprotein B mRNA. J. Biol. Chem. 266: 16301-16304.
55. 2 synthesis. Arteriosclerosis 8: 359-367.
56. Sonenberg, N. 1993. Translation factors as effectors of cell growth and tumorigenesis. Curr. Opin. Cell Biol. 5: 955-960.
57. _. 1996. mRNA 5′ cap-binding protein eIF4E and control of cell growth. In Translational control (ed. J.W.B. Hershey, M.B. Mathews, and N. Sonenberg), pp. 245-269. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Teerink, H., H.O. Voorma, and A.A.M. Thomas. 1995. The human insulin-like growth factor II leader 1 contains an internal ribosomal entry site. Biochim. Biophys. Acta. 1264: 403-408.
59. Teng, B., C.F. Burant, and N.O. Davidson. 1993. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816-1819.
60. Thach, R.E. 1992. Cap recap: The involvement of eIF-4F in regulating gene expression. Cell 68: 177-180.
61. Vagner, S., M.-C. Gensac, A. Maret, F. Bayard, F. Amalric, H. Prats, and A.-C. Prats. 1995. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol. 15: 35-44.
62. Yamanaka, S., K.S. Poksay, M.E. Balestra, G.-Q. Zeng, and T.L. Innerarity. 1994. Cloning and mutagenesis of the rabbit apoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J. Biol. Chem. 269: 21725-21734.
63. Yamanaka, S., M.E. Balestra, L.D. Ferrell, J. Fan, K.S. Arnold, S. Taylor, J.M. Taylor, and T.L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. 92: 8483-8487.
64. Yamanaka, S., K.S. Poksay, D.M. Driscoll, and T.L. Innerarity. 1996. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J. Biol. Chem. 271: 11506-11510.
65. Yan, R. and R.E. Rhoads. 1995. Human protein synthesis initiation factor eIF-4γ is encoded by a single gene (EIF4G) that maps to chromosome 3q27-qter. Genomics 26: 394-398.
66. Yan, R., W. Rychlik, D. Etchison, and R.E. Rhoads. 1992. Amino acid sequence of the human protein synthesis initiation factor eIF-4γ. J. Biol. Chem. 267: 23226-23231.